期刊文献+
共找到179篇文章
< 1 2 9 >
每页显示 20 50 100
蜂王浆精华片抗氧化能力临床试食观察
1
作者 张聪恪 张丁 +4 位作者 王海玉 李立 张焱 徐冰 陈东方 《中医药临床杂志》 2012年第12期1151-1152,共2页
目的:观察蜂王浆精华片对人体的抗氧化作用。方法:采用自身和组间2种对照方法设立试食组和对照组,试食组服用蜂王浆精华片,对照组服用安慰剂,90d后进行相关安全性指标及功效指标测定。结果:试食前后各项安全性指标均在正常范围内,且未... 目的:观察蜂王浆精华片对人体的抗氧化作用。方法:采用自身和组间2种对照方法设立试食组和对照组,试食组服用蜂王浆精华片,对照组服用安慰剂,90d后进行相关安全性指标及功效指标测定。结果:试食前后各项安全性指标均在正常范围内,且未发现明显不良反应。试食后试食组血清SOD、GSH-Px活力分别较试验前提高15.40%、5.74%。血清MDA降低12.90%。试食组试食后血清SOD、MDA与试验前及对照组后比较,差异均有显著的统计学意义(P<0.01,P<0.05)。结论:蜂王浆精华片对人体安全且具有抗氧化作用。 展开更多
关键词 蜂王浆精华片 临床试 安全性 抗氧化作用
在线阅读 下载PDF
猪瘟的临床试治 被引量:1
2
作者 汪成发 《中兽医医药杂志》 2002年第2期44-44,共1页
关键词 猪瘟 临床试 中西医联合治疗
在线阅读 下载PDF
注射用聚乙二醇化重组人粒细胞集落刺激因子I期临床耐受性试验 被引量:31
3
作者 石远凯 刘鹏 +8 位作者 杨晟 韩晓红 何小慧 艾斌 秦燕 李博 黄鼎智 张长弓 孙燕 《癌症》 SCIE CAS CSCD 北大核心 2006年第4期495-500,共6页
背景与目的:重组人粒细胞集落刺激因子(rhG-CSF)是防治肿瘤化放疗引起的中性粒细胞减少症的有效药物,但半衰期短,需每日给药。聚乙二醇化重组人粒细胞集落刺激因子(PEG-rhG-CSF)是将聚乙二醇与rhG-CSF结合而成的长效制剂,与常规rhG-CSF... 背景与目的:重组人粒细胞集落刺激因子(rhG-CSF)是防治肿瘤化放疗引起的中性粒细胞减少症的有效药物,但半衰期短,需每日给药。聚乙二醇化重组人粒细胞集落刺激因子(PEG-rhG-CSF)是将聚乙二醇与rhG-CSF结合而成的长效制剂,与常规rhG-CSF相比,能减少给药次数,避免患者反复接受注射的痛苦。本研究旨在评价PEG-rhG-CSF用于国人的安全性和耐受性,初步观察化疗后PEG-rhG-CSF升高外周血中性粒细胞和CD34+细胞的效果。方法:本研究为开放性试验,经病理组织学或细胞学确诊的初治非小细胞肺癌和乳腺癌患者进入本研究,受试者接受两个周期相同方案的化疗,第一周期为对照周期,第二周期在化疗药物给药结束后48h给予PEG-rhG-CSF。PEG-rhG-CSF的初始剂量为30#g/kg,递增剂量依次为60#g/kg、100#g/kg和200#g/kg,每一剂量组4例受试患者。结果:入组16例患者均可评价疗效和安全性。与PEG-rhG-CSF相关的不良反应主要有骨关节或肌肉疼痛(13/16)、疲乏(10/16)、头晕(2/16),1例受试患者出现注射部位轻度疼痛,自行缓解。与对照周期相比,使用PEG-rhG-CSF后中性粒细胞绝对值(ANC)最低值的出现时间前移,ANC最低值提高。ANC的变化呈现一定程度的量效关系,60、100和200#g/kg剂量组均能较好地防治化疗后的中性粒细胞减少症,且维持时间较长,并能够增高外周血CD34+细胞的数量。未出现PEG-rhG-CSF的剂量限制性毒性,也未达到最大耐受剂量。结论:PEG-rhG-CSF显示了良好的耐受性,未出现严重不良事件。由于100#g/kg剂量组的不良反应轻于200#g/kg剂量组,疗效已能满足临床需要,因此推荐Ⅱ期临床试验的剂量为100#g/kg。 展开更多
关键词 肿瘤 聚乙二醇化 粒细胞集落刺激因子 临床试 Ⅰ期 药物耐受性
在线阅读 下载PDF
Reporting quality of randomized controlled trials on acupuncture and manipulation for greater occipital neuralgia evaluated using the CONSORT statement and STRICTA checklist
4
作者 Liu Liguo Qiu Mingwang +3 位作者 Huang Yanling Fan Zhiyong Wu Shan Guo Rusong 《中国组织工程研究》 北大核心 2025年第30期6566-6573,共8页
OBJECTIVE:In recent years,the number of clinical research reports on acupuncture and manipulation for the treatment of greater occipital neuralgia has gradually increased,but the quality is uneven.There is currently n... OBJECTIVE:In recent years,the number of clinical research reports on acupuncture and manipulation for the treatment of greater occipital neuralgia has gradually increased,but the quality is uneven.There is currently no literature evaluating the quality of published reports,which is not conducive to the promotion of clinical use of these therapies.Therefore,this article assessed the reporting quality of randomized controlled trials on acupuncture and manipulation for greater occipital neuralgia.METHODS:Cochrane Library,PubMed,Web of Science,Embase,China National Knowledge Infrastructure(CNKI),VIP,WanFang Data,and Chinese BioMedical Literature Database(CBM)from inception to May 20,2024 were searched.The reporting quality of included randomized controlled trials was independently evaluated by two investigators using the CONSORT statement,STRICTA checklist,and Cochrane bias of risk assessment tool.A third investigator resolved any disagreement.RESULTS:A total of 62 articles were included.Based on the CONSORT statement,59.46%(22/37)of all entries had a reporting rate of less than 50%,mainly including“Identification as a randomized trial in the title(1/62,1.61%),”“How sample size was determined(7/62,11.29%),”“Implementation(1/62,1.61%),”“Blinding(1/62,1.61%),”and“Reports of Funding(4/62,6.45%).”According to the STRICTA checklist,29.41%(5/17)of all entries had a reporting rate of less than 50%,mainly including“Details of other interventions(7/58,12.07%),”“Setting and context of treatment(0/58,0%),”and“Description of participating acupuncturists(0/58,0%).”CONCLUSION:The reporting quality of randomized controlled trials on acupuncture and manipulation therapy for greater occipital neuralgia remains low.Future researchers need to make greater efforts to strictly adhere to the CONSORT statement and STRICTA checklist during trial design,implementation,and reporting.This will facilitate the standardization of research in this field and enhance the reliability and reproducibility of the research results. 展开更多
关键词 reporting quality ACUPUNCTURE MANIPULATION CONSORT statement STRICTA checklist ROB clinical randomized controlled trials greater occipital neuralgia
在线阅读 下载PDF
破伤风抗毒素对患者不同部位皮试结果的影响分析 被引量:1
5
作者 罗玲 宗飞红 +1 位作者 谢朝京 阳珍玉 《抗感染药学》 2015年第4期562-564,共3页
目的:分析破伤风抗毒素(TAT)在患者不同部位注射对皮试结果的影响。方法:选取2014年1—5月期间门诊注射室行TAT皮试患者72例,将其分成两组;实验组患者给予在前臂掌侧中段1/3处行TAT皮试,对照组患者给予在前臂掌侧下段1/3段内侧行TAT皮试... 目的:分析破伤风抗毒素(TAT)在患者不同部位注射对皮试结果的影响。方法:选取2014年1—5月期间门诊注射室行TAT皮试患者72例,将其分成两组;实验组患者给予在前臂掌侧中段1/3处行TAT皮试,对照组患者给予在前臂掌侧下段1/3段内侧行TAT皮试;20 min后观察、判定、记录其皮试结果。结果:实验组患者假阳性率为25.00%显著低于对照组患者为78.60%(P<0.05)。结论:采用前臂掌侧中1/3部位行TAT皮试其结果示假阳性率低,减少和减轻了患者多次数皮试带来的痛苦,缩短了就诊时间,也降低了护士的工作量。 展开更多
关键词 破伤风抗毒素(TAT) 不同部位皮 结果临床研究
在线阅读 下载PDF
A Rumsfeld Matrix test for acupuncture clinical trials
6
作者 GONG Changzhen 《Digital Chinese Medicine》 CAS CSCD 2024年第3期209-223,共15页
This study examined the application of the Rumsfeld Matrix to acupuncture clinical trials,particularly those published in leading medical journals such as The Journal of the American Medical Association(JAMA),British ... This study examined the application of the Rumsfeld Matrix to acupuncture clinical trials,particularly those published in leading medical journals such as The Journal of the American Medical Association(JAMA),British Medical Journal(BMJ),The Lancet,and The New Eng-land Journal of Medicine(NEJM).The integration of randomized clinical trials(RCTs)has in-troduced a level of academic rigor to acupuncture research,challenging the classical deter-ministic model and revealing a complex landscape of known knowns,known unknowns,un-known knowns,and unknown unknowns.While RCTs have validated acupuncture’s efficacy in certain conditions,they have also highlighted considerable challenges,including the limi-tations of control group designs and the potential influence of placebo effects.The recurring issue of no significant differences between real and sham acupuncture in many studies un-derscores the need for refined control strategies and a more nuanced understanding of acupuncture’s mechanisms.This investigation calls for continued rigorous research to fully explore acupuncture’s therapeutic potential and its integration into evidence-based medicine,ultimately contributing to improved patient care and broader acceptance within the medical community. 展开更多
关键词 ACUPUNCTURE Randomized clinical trials(RCTs) Rumsfeld Matrix Placebo effect Control group design Therapeutic potential
在线阅读 下载PDF
乳腺癌风险相适应的靶向术中放疗与全乳外放射治疗的比较 被引量:2
7
作者 廖宁 钱学珂 《循证医学》 CSCD 2014年第3期157-159,165,共4页
1文献来源 Vaidya JS, Wenz F, Bulsara M, et al. Riskadapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TAR... 1文献来源 Vaidya JS, Wenz F, Bulsara M, et al. Riskadapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial[J]. Lancet, 2014,383 (9917) :603-613. 展开更多
关键词 乳腺癌 术中放疗 全乳外放射治疗 临床试 Ⅲ期
在线阅读 下载PDF
迈入新世纪的硼中子俘获疗法(BNCT) 被引量:14
8
作者 周永茂 《中国工程科学》 北大核心 2012年第8期4-13,共10页
扼要叙述进入21世纪之际,硼中子俘获疗法(boron neutorn capture therapy,BNCT)在国际范围内的一些显著进展,包括BNCT的临床定位、肿瘤复发的探索、硼浓度的定量探测、靶向掺硼药物的开发以及我国医院中子照射器的问世。这些BNCT长期开... 扼要叙述进入21世纪之际,硼中子俘获疗法(boron neutorn capture therapy,BNCT)在国际范围内的一些显著进展,包括BNCT的临床定位、肿瘤复发的探索、硼浓度的定量探测、靶向掺硼药物的开发以及我国医院中子照射器的问世。这些BNCT长期开发中的瓶颈趋于缓解,预示了BNCT个性化与例行化的前景更为清晰。 展开更多
关键词 中子俘获疗法 临床试 肿瘤复发 硼浓度探测 靶向药物 医院中子照射器
在线阅读 下载PDF
Safety and Tolerance of Adefovir Dipivoxil in Chinese Healthy Volunteers: A PhaseⅠRandomized and Open-Label Trial
9
作者 孙德清 倪梅媛 +1 位作者 王本杰 郭瑞臣 《Journal of Chinese Pharmaceutical Sciences》 CAS 2005年第4期217-222,共6页
Aim To assess the safety and tolerance of adefovir dipivoxil (ADV) in Chinese healthy volunteers. Methods A total of 52 healthy volunteers, 26 males and 26 females, aged from 19 to 26 were enrolled in the study. For... Aim To assess the safety and tolerance of adefovir dipivoxil (ADV) in Chinese healthy volunteers. Methods A total of 52 healthy volunteers, 26 males and 26 females, aged from 19 to 26 were enrolled in the study. Forty-two subjects were randomized into 5, 10, 20, 40, and 60 mg dose groups (6 - 10 subjects in each) matched by sex and weight for single-dose trial. Ten subjects were orally given 10 mg of ADV tablets once daily for 7 d for multiple-dose trial. Physical examination, vital signs examination, electrocardiography, type-B ultrasonography, chest fluoroscopy, routine blood test, routine urine test, coagulation tests, and blood biochemical test were conducted on schedule and statistically evaluated. Results Asthenia frequently occurred in multiple-dose trial, nausea, abdominal pain, and diarrhea occurred in both single- and multiple-dose trials. ALT, bilirubin, CK, and LDH were slightly elevated. All adverse reactions and laboratory abnormalities were mild, and the frequency and severity were not related to doses. Conclusion ADV is safe and well tolerated in Chinese healthy volunteers at dose of 5 - 60 mg oncedaily or 10 nag once daily for 7 d. The recommended oral dosage regimen is 10 mg once daily. Attention should be paid to renal and liver functions, CK, AMY and LDH, if we take ADV for a long period of time. 展开更多
关键词 adefovir dipivoxil SAFETY TOLERANCE phaseⅠtrial
在线阅读 下载PDF
功能性消化不良、胃排空延迟与生活质量下降的关系 被引量:1
10
作者 Talley N.J. Locke III G.R. +1 位作者 LahrB.D. 尹勇 《世界核心医学期刊文摘(胃肠病学分册)》 2006年第11期31-32,共2页
Background: It remains controversial as to whether delayed gastric emptying in functional dyspepsia is associated with a specific symptom pattern, and it is unknown if gastric emptying in functional dyspepsia is a dri... Background: It remains controversial as to whether delayed gastric emptying in functional dyspepsia is associated with a specific symptom pattern, and it is unknown if gastric emptying in functional dyspepsia is a driver of impaired health related quality of life (HRQOL). We aimed to evaluate the relationship between functional dyspepsia symptoms, gastric emptying, and HRQOL. Methods: US patients (n = 864; mean age 44 years (range 18-82); 74%female) with functional dyspepsia, as defined by Rome Ⅱ criteria, were enrolled into one of four clinical trials. All patients had a baseline scintigraphic assessment of gastric emptying of an egg substitute meal, and the trials were stratified on this assessment. Delayed gastric emptying was defined as having at least 6.3%residual volume at four hours. A total of 290 (34%) patients had delayed gastric emptying. HRQOL was assessed by the SF 36 and Nepean dyspepsia index (NDI). Results: Postprandial fullness was independently associated with delayed gastric emptying but the association was weak (odds ratio (OR) 1.98 (95%confidence interval (CI) 1.02, 3.86); p = 0.04). No independent association was seen with epigastric pain, early satiety, nausea, or bloating. Mean SF 36 physical composite score (PCS) was 42.3 (95%CI 41.6, 43.0) and the mean SF 36 mental composite score (MCS) was 46.8 (95%CI 46.0, 47.5); both mean scores were significantly lower than age and sex adjusted national norms of 50 (p < .0001). Female sex, increasing age, and higher symptom scores for fullness, epigastric pain, and nausea were each independently associated with decreased PCS scores (all p < 0.05). Higher baseline nausea symptom score, lower gastric emptying rates at one hour, and lower body mass index were associated with decreased MCS (all p < 0.05). Female sex, epigastric pain, and nausea, but not gastric emptying, were associated with an impaired score on the NDI. However, the magnitude of the significant associations were all small. Conclusions: In patients with functional dyspepsia selected for a clinical trial programme, gastric emptying did not usefully stratify them symptomatically. Quality of life of patients with functional dyspepsia enrolled in this clinical trial programme was significantly impaired but this was not explained by delayed gastric emptying. 展开更多
关键词 胃排空延迟 生活质量 胃排空率 罗马Ⅱ标准 闪烁扫描 促发因素 特异性症状 胃残留 恶心症状 临床试
在线阅读 下载PDF
哪些因素与ST段抬高型急性冠状动脉综合征患者中再灌注治疗的应用有关?来自急性冠状动脉综合征的欧洲心脏调查I的经验
11
作者 Nieuwlaat R. Lenzen M. +2 位作者 Crijns H.J.G.M. E. Boersma 孙志军 《世界核心医学期刊文摘(心脏病学分册)》 2007年第3期39-39,共1页
背景/目的:有相当大比例的ST段抬高型急性冠状动脉综合征患者未接受再灌注治疗。为促进对临床决策过程更好的理解,作者分析了与应用再灌注治疗相关的因素。
关键词 ST段抬高 再灌注治疗 欧洲心脏 临床决策 延误时间 梗死面积 介入治疗 治疗经历 医院设备 临床试
在线阅读 下载PDF
对极低出生体重儿添加维生素A及其18~22月龄时的转归
12
作者 Ambalavanan N. Tyson J.E. +2 位作者 Kennedy K.A. N. Ambalavanan 王一飞 《世界核心医学期刊文摘(儿科学分册)》 2006年第A10期56-57,共2页
Background. A National Institute of Child Health and Human Development Neonatal Research Network randomized trial showed that vitamin A supplementation reduced bronchopulmonary dysplasia (O2 at 36 weeks’ postmenstrua... Background. A National Institute of Child Health and Human Development Neonatal Research Network randomized trial showed that vitamin A supplementation reduced bronchopulmonary dysplasia (O2 at 36 weeks’ postmenstrual age) or death in extremely low birth weight (ELBW) neonates (relative risk [RR]: 0.89). As with postnatal steroids or other interventions, it is important to ensure that there are no longer- term adverse effects that outweigh neonatal benefits. Primary Objective. To determine if vitamin A supplementation in ELBW infants during the first month after birth affects survival without neurodevelopmental impairment at a corrected age of 18 to 22 months. Design/Methods. Infants enrolled in the National Institute of Child Health and Human Development vitamin A trial were evaluated at 18 to 22 months by carefully standardized assessments: Bayley Mental Index (MDI) and Psychomotor Index (PDI), visual and hearing screens, and physical examination for cerebral palsy (CP). The medical history was also obtained. Neurodevelopmental impairment (NDI) was predefined as ≥ 1 of MDI < 70, PDI < 70, CP, blind in both eyes, or hearing aids in both ears. Results. Of 807 enrolled infants, 133 died before and 16 died after discharge. Five hundred seventy- nine (88% ) of the 658 remaining infants were followed up. The primary outcome of NDI or death could be determined for 687 of 807 randomized infants (85% ). Baseline characteristics and predischarge and postdischarge mortality were comparable in both study groups. NDI or death by 18 to 22 months occurred in 190 of 345 (55% ) infants in the vitamin A group and in 204 of 342 (60% ) of the control group (RR: 0.94; 95% confidence interval: 0.80- 1.07). RRs for low MDI, low PDI, and CP were also < 1.0. We found no evidence that neonatal vitamin A supplementation reduces hospitalizations or pulmonary problems after discharge. Conclusion. Vitamin A supplementation for ELBW infants reduces bronchopulmonary dysplasia without increasing mortality or neurodevelopmental impairment at 18 to 22 months. However, this study was not powered to evaluate small magnitudes of change in long- term outcomes. 展开更多
关键词 极低出生体重儿 加维生素 发育性 国家儿童 住院天数 神经发育 运动指数 体格检查 干预手段 临床试
在线阅读 下载PDF
胚胎早期原核形态(合子评分)与受精第2~3天胚胎形态评分预测辅助生育技术妊娠结局的比较
13
作者 Payne J.F. Raburn D.J. +2 位作者 Couchman G.M. D.K. Walmer 张剑萍 《世界核心医学期刊文摘(妇产科学分册)》 2006年第2期28-28,共1页
Objective: To test the hypothesis that pregnancy rates are low if grade Z1 pre-embryos are not available for transfer and to determine if pronuclear morphology is a better predictor of pregnancy than traditional embry... Objective: To test the hypothesis that pregnancy rates are low if grade Z1 pre-embryos are not available for transfer and to determine if pronuclear morphology is a better predictor of pregnancy than traditional embryo morphology. Design: Prospective clinical study. Setting: Academic human reproduction laboratory. Patient(s): One hundred couples undergoing IVF with conventional insemination or ICSI. Intervention(s): Embryo quality was assessed using both pre-embryo pronuclear morphology (zygote scoring or Z-scoring) at the time of fertilization evaluation and standard day 2 and day 3 embryo morphology (number of blastomeres and grading based on degree of fragmentation and blastomere size). Main Outcome Measure(s): We tested two decision models, one based on Z scores and another on morphology, to determine which grading system better predicted pregnancy outcomes in assisted reproductive technique. Zygote score and embryo morphology were measured for all embryos and the transferred embryo pool. Implantation and pregnancy rates resulting from the embryo transfers of all cycles were calculated. Result(s): The Z-score distribution of 552 embryos was 27%Z1, 8%Z2, 50%Z3, and 15%Z4. Z1 and Z3 embryos had significantly (P~.03) higher quality over Z2 and Z4 embryos. Using the Z-score decision model with Z1 embryos having highest priority for transfer, pregnancy rates were similar between Z1 and Z3 embryos. Using embryo morphology as a decision model, pregnancy rates were highest in transfers containing one or two “best”-quality embryos. Conclusion(s): Z1 and Z3 embryos had similar morphology and pregnancy rates. The decision model based on the Z-score model was not better than standard embryo morphology in predicting pregnancy outcome. 展开更多
关键词 原核形态 辅助生育技术 妊娠结局 胚胎数 卵裂球 人工受精 胚胎移植 种植率 卵母细胞 前瞻性临床试
在线阅读 下载PDF
Fast-track rehabilitation program vs conventional care after colorectal resection:A randomized clinical trial 被引量:43
14
作者 Gang Wang Zhi-Wei Jiang +4 位作者 Jing Xu Jian-Feng Gong Yang Bao Li-Fei Xie Jie-Shou Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第5期671-676,共6页
AIM:To compare the fast-track rehabilitation program and conventional care for patients after resection of colorectal cancer.METHODS:One hundred and six consecutive patients who underwent fast-track rehabilitation pro... AIM:To compare the fast-track rehabilitation program and conventional care for patients after resection of colorectal cancer.METHODS:One hundred and six consecutive patients who underwent fast-track rehabilitation program were encouraged to have early oral feeding and movement for early discharge,while 104 consecutive patients underwent conventional care after resection of colorectal cancer.Their gastrointestinal functions,postoperative complications and hospital stay time were recorded.RESULTS:The restoration time of gastrointestinal functions in the patients was significantly faster after fasttrack rehabilitation program than after conventional care(2.1 d vs 3.2 d,P < 0.01).The percentage of patients who developed complications was significantly lower 30 d after fast-track rehabilitation program than after conventional care(13.2% vs 26.9%,P < 0.05).Also,the percentage of patients who had general complications was significantly lower 30 d after fast-track rehabilitation program than after conventional care(6.6% vs 15.4%,P < 0.05).The postoperative hospital stay time of the patients was shorter after fast-track rehabilitation program than after conventional care(5 d vs 7 d,P < 0.01).No significant difference was observed in the readmission rate 30 d after fast-track rehabilitation program and conventional care(3.8% vs 8.7%).CONCLUSION:The fast-track rehabilitation program can significantly decrease the complications and shorten the time of postoperative hospital stay of patients after resection colorectal cancer. 展开更多
关键词 Perioperative care Fast track Rehabilita-tion Colorectal cancer resection
在线阅读 下载PDF
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010 被引量:32
15
作者 Chakshu Sharma Karim M Eltawil +2 位作者 Paul D Renfrew Mark J Walsh Michele Molinari 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第7期867-897,共31页
Several advances in genetics, diagnosis and palliation of pancreatic cancer (PC) have occurred in the last decades. A multidisciplinary approach to this disease is therefore recommended. PC is relatively common as it ... Several advances in genetics, diagnosis and palliation of pancreatic cancer (PC) have occurred in the last decades. A multidisciplinary approach to this disease is therefore recommended. PC is relatively common as it is the fourth leading cause of cancer related mortality. Most patients present with obstructive jaundice, epigastric or back pain, weight loss and anorexia. Despite improvements in diagnostic modalities, the majority of cases are still detected in advanced stages. The only curative treatment for PC remains surgical resection. No more than 20% of patients are candidates for surgery at the time of diagnosis and survival remains quite poor as adjuvant therapies are not very effective. A small percentage of patients with borderline non-resectable PC might benefit from neo-adjuvant chemoradiation therapy enabling them to undergo resection; however, randomized controlled studies are needed to prove the benefits of this strategy. Patients with unresectable PC benefit from palliative interventions such as biliary decompression and celiac plexus block. Further clinical trials to evaluate new chemo and radiation protocols as well as identification of genetic markers for PC are needed to improve the overall survival of patients affected by PC, as the current overall 5-year survival rate of patients affected by PC is still less than 5%. The aim of this article is to review the most recent high quality literature on this topic. 展开更多
关键词 DIAGNOSIS EPIDEMIOLOGY PALLIATION Pancreatic cancer THERAPY
在线阅读 下载PDF
Serial observations on an orthotopic gastric cancer model constructed using improved implantation technique 被引量:15
16
作者 Yan Li Bo Li +3 位作者 Yu Zhang Chun-Ping Xiang Yuan-Yuan Li Xiao-Ling Wu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第11期1442-1447,共6页
AIM:To establish a gastric cancer nude-mouse model with improved orthotopic implantation and investigate its biological characteristics at different time points.METHODS:Human gastric cancer SGC-7901 cell suspensions w... AIM:To establish a gastric cancer nude-mouse model with improved orthotopic implantation and investigate its biological characteristics at different time points.METHODS:Human gastric cancer SGC-7901 cell suspensions were injected subcutaneously into a nude mouse to develop solid tumors,and the tumor tissue pieces were implanted under the serous coat.The nude mice were then euthanized in group every two weeks to observe the primary tumor growth and metastases.RESULTS:Within 2-4 wk,there were no obvious chang-es about the primary tumor in stomach.At the sixth week,the primary tumor began to grow fast,resulting in incrassation of the gastric wall and stenosis of the gastric cavity,and metastases into the liver and lymph nodes were detected.The tumor,which compressed the adjacent organs,gradually became bigger and bigger followed by stenosis or vanishment of the gastric cavity from 8 to 12 wk.There were massive metastases,and the rate of metastasis was 58%in lymph nodes,78%in liver,39%in kidney,and 81%in peritoneum or septum.CONCLUSION:A gastric cancer model is established,which can simulate the clinical tumor behavior and provide experimental carrier for clinical trials of gastric cancer treatment. 展开更多
关键词 Gastric cancer Orthotopic implantation Mouse model METASTASIS Cell line
在线阅读 下载PDF
A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine 被引量:27
17
作者 Jiang Lin Wei-Wen Huang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第37期4715-4719,共5页
AIM: To evaluate the efficacy and safety of Traditional Chinese Medicine (TCM) in the treatment of Helicobacter pylori (H pylori) infection. METHODS: We electronically and manually searched electronic databases, refer... AIM: To evaluate the efficacy and safety of Traditional Chinese Medicine (TCM) in the treatment of Helicobacter pylori (H pylori) infection. METHODS: We electronically and manually searched electronic databases, references lists and conferences compilations, and included all randomized clinical trials comparing the treatment of H pylori using TCM with proton pump inhibitor or colloidal bismuth subcitratebased triple therapy as controls. The Jadad score was used to assess trial quality, H pylori eradication rate and the incidence of side effects were taken as outcome measurements, and heterogeneity analysis, meta-analysis and funnel plot analysis were conducted. RESULTS: Sixteen trials were included. The Jadad scores of all the trials were not more than 2. Clinical heterogeneity and substantial statistical heterogeneity existed among the trials (P = 0.001, I 2 = 59%) and meta-analysis was not conducted. The average eradication rates following TCM and triple therapy were 72% and 78% and the incidence of side effects were 2% and 29%, respectively. The funnel plot was obviously asymmetric. CONCLUSION: Available evidence is not convincing enough to show that TCM has the same efficacy as triple therapy in H pylori treatment. TCM may be safer than triple therapy. TCM should not be recommended as monotherapy in H pylori infection. 展开更多
关键词 Drug toxicity Helicobacter pylori Traditional Chinese Medicine Treatment efficacy
在线阅读 下载PDF
An overview of PCI in the very elderly 被引量:22
18
作者 Vimalraj Bogana Shanmugam Richard Harper Ian Meredith Yuvaraj Malaiapan Peter J Psaltis 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第2期174-184,共11页
Cardiovascular disease, and in particular ischemic heart disease (IHD), is a major cause of morbidity and mortality in the very elderly (〉 80 years) worldwide. These patients represent a rapidly growing cohort pr... Cardiovascular disease, and in particular ischemic heart disease (IHD), is a major cause of morbidity and mortality in the very elderly (〉 80 years) worldwide. These patients represent a rapidly growing cohort presenting for percntaneous coronary intervention (PCI), now constituting more than one in five patients treated with PCI in real-world practice. Furthermore, they often have greater ischemic burden than their younger counterparts, suggesting that they have greater scope of benefit from coronary revascularization therapy. Despite this, the very elderly are frequently under-represented in clinical revascularization trials and historically there has been a degree of physician reluctance in referring them for PCI procedures, with perceptions of disappointing outcomes, low success and high complication rates. Several issues have contributed to this, including the tendency for older patients with IHD to present late, with atypical symptoms or non-diagnostic ECGs, and reservations regarding their procedural risk-to-benefit ratio, due to shorter life expectancy, presence of comorbidities and increased bleeding risk from antiplatelet and anticoagulation medications. However, advances in PCI technology and techniques over the past decade have led to better outcomes and lower risk of complications and the existing body of evidence now indicates that the very elderly actually derive more relative benefit from PCI than younger populations. Importantly, this applies to all PCI settings: elective, urgent and emergency. This review discusses the role of PCI in the very elderly presenting with chronic stable IHD, non ST-elevation acute coronary syndrome, and ST-elevation myocardial infarction. It also addresses the clinical challenges met when considering PCI in this cohort and the ongoing need for research and development to further improve outcomes in these challenging patients. 展开更多
关键词 Acute coronary syndrome ANGINA Antithrombotic therapy Myocardial infarction OCTOGENARIANS Percutaneous coronary intervention The elderly
在线阅读 下载PDF
Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases 被引量:20
19
作者 Madharasi VA Pichai Lynnette R Ferguson 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第23期2895-2901,共7页
Inflammatory bowel diseases (IBDs) such as Crohn's disease are highly debilitating. There are inconsistencies in response to and side effects in the current conventional medications, failures in adequate drug deli... Inflammatory bowel diseases (IBDs) such as Crohn's disease are highly debilitating. There are inconsistencies in response to and side effects in the current conventional medications, failures in adequate drug delivery, and the lack of therapeutics to offer complete remission in the presently available treatments of IBD. This suggests the need to explore beyond the horizons of conventional approaches in IBD therapeutics. This review examines the arena of the evolving IBD nanomedicine, studied so far in animal and in vitro models, before comprehensive clinical testing in humans. The investigations carried out so far in IBD models have provided substantial evidence of the nanotherapeutic approach as having the potential to overcome some of the current drawbacks to conventional IBD therapy. We analyze the pros and cons of nanotechnology in IBD therapies studied in different models, aimed at different targets and mechanisms of IBD pathogenesis, in an attempt to predict its possible impact in humans. 展开更多
关键词 Inflammatory bowel disease Crohn's disease Ulcerative colitis Tumor necrosis factor-m NANOMEDICINE
在线阅读 下载PDF
Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma 被引量:15
20
作者 Ju-Xian Sun Jie Shi +4 位作者 Nan Li Wei-Xing Guo Meng-Chao Wu Wan-Yee Lau Shu-Qun Cheng 《Cancer Biology & Medicine》 SCIE CAS CSCD 2016年第4期452-458,共7页
The effect of portal vein tumor thrombus(PVTT) on the prognosis of patients with hepatocellular carcinoma has become clear over the past several decades. However, identifying the mechanisms and performing the diagnosi... The effect of portal vein tumor thrombus(PVTT) on the prognosis of patients with hepatocellular carcinoma has become clear over the past several decades. However, identifying the mechanisms and performing the diagnosis and treatment of PVTT remain challenging. Therefore, this study aimed to summarize the progress in these areas. A computerized literature search in Medline and EMBASE was performed with the following combinations of search terms: "hepatocellular carcinoma" AND "portal vein tumor thrombus." Although several signal transduction or molecular pathways related to PVTT have been identified, the exact mechanisms of PVTT are still largely unknown. Many biomarkers have been reported to detect microvascular invasion, but none have proved to be clinically useful because of their low accuracy rates. Sorafenib is the only recommended therapeutic strategy in Western countries. However, more treatment options are recommended in Eastern countries, including surgery, radiotherapy(RT), transhepatic arterial chemoembolization(TACE), transarterial radioembolization(TARE), and sorafenib. Therefore, we established a staging system based on the extent of portal vein invasion. Our staging system effectively predicts the long-term survival of PVTT patients. Currently, several clinical trials had shown that surgery is effective and safe in some PVTT patients. RT,TARE, and TACE can also be performed safely in patients with good liver function. However, only a few comparative clinical trials had compared the effectiveness of these treatments. Therefore, more randomized controlled trials examining the extent of PVTT should be conducted in the future. 展开更多
关键词 Biomarkers SURGERY transhepatic arterial chemoembolization SORAFENIB REVIEW
在线阅读 下载PDF
上一页 1 2 9 下一页 到第
使用帮助 返回顶部